Vigabatrin Tablet, Film Coated
Product Images NDC 70771-1654

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70771-1654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dda2d40b 9f09 4d9f 9073 6f6be5024838 01)

Chemical structure of vigabatrin, showing its molecular configuration with labeled functional groups including an amino group, a carboxylic acid group, and a vinyl side chain.*

FDA Label Image

Image (Dda2d40b 9f09 4d9f 9073 6f6be5024838 02)

A line graph illustrating the percentage reduction in seizure frequency versus the percentage of patients. The graph compares four treatment groups: placebo, 1g/day vigabatrin (VGB), 3g/day VGB, and 6g/day VGB. The vertical axis indicates seizure frequency change, with improvement above and worsening below the zero line; the horizontal axis shows the percentage of patients. Lines show varying efficacy levels by dosage.*

FDA Label Image

Image (Dda2d40b 9f09 4d9f 9073 6f6be5024838 03)

A cumulative distribution plot comparing percent reduction in seizure frequency among patients treated with 3 g/day of vigabatrin (VGB) versus placebo. The horizontal axis represents the percentage of patients, and the vertical axis shows percent reduction in seizure frequency, with improvement upward and worsening downward. Two lines indicate the responses for placebo and vigabatrin groups.*

FDA Label Image

Image (Dda2d40b 9f09 4d9f 9073 6f6be5024838 04)

Label for Vigabatrin Tablets, USP 500 mg, film-coated oral tablets. The label indicates a package size of 100 tablets, manufactured by Zydus Lifesciences Limited and Cadila Healthcare Ltd., India. It includes storage instructions, child-resistant packaging notice, and directs pharmacists to provide a medication guide. Barcode and NDC 70771-1654-1 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.